The study suggests simplifying guidelines to recommend low-dose aspirin for pregnant individuals with any single moderate-risk factor for preeclampsia.
May simplify aspirin recommendations for moderate-risk preeclampsia; leaves open need for randomized confirmation before practice change.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Wheeler et al. (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: